Qiagen NV Company Profile (NASDAQ:QGEN)

Analyst Ratings

Consensus Ratings for Qiagen NV (NASDAQ:QGEN) (?)
Ratings Breakdown: 1 Sell Rating(s), 5 Hold Rating(s), 5 Buy Rating(s)
Consensus Rating:Hold (Score: 2.36)
Consensus Price Target: $25.30 (9.38% upside)

Analysts' Ratings History for Qiagen NV (NASDAQ:QGEN)
Show:
DateFirmActionRatingPrice TargetActions
7/25/2016Piper Jaffray Cos.Reiterated RatingNeutral$23.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/8/2016Morgan StanleyReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/6/2016Deutsche Bank AGReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/15/2016Citigroup Inc.Lower Price TargetNeutral$28.00 -> $25.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/4/2016DZ Bank AGReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/3/2016Barclays PLCLower Price TargetOverweight$28.00 -> $27.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/19/2016Commerzbank AGLower Price TargetBuy$30.00 -> $28.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/7/2016Cowen and CompanyBoost Price Target$24.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/12/2015Stifel NicolausInitiated CoverageHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/30/2015Goldman Sachs Group Inc.Lower Price Target$22.00 -> $21.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/29/2015WedbushLower Price TargetNeutral$21.00 -> $20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/30/2015MizuhoBoost Price TargetNeutral$23.00 -> $25.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/28/2015Credit Suisse Group AGReiterated RatingNeutral$24.00 -> $25.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/18/2015Jefferies GroupBoost Price TargetHold$24.00 -> $25.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/6/2015JPMorgan Chase & Co.DowngradeOverweight -> Neutral$28.00 -> $25.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/6/2015Bank of America Corp.DowngradeNeutral -> Underperform$26.00 -> $24.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/31/2014Leerink SwannBoost Price Target$24.00 -> $26.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/26/2014 forward)

Earnings

Earnings History for Qiagen NV (NASDAQ:QGEN)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
7/28/2016Q216$0.23$326.73 millionN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/27/2016Q116$0.19$0.19$295.76 million$298.40 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/2/2016Q415$0.32$0.33$354.47 million$349.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/28/2015Q315$0.28$0.27$323.50 million$314.60 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/29/2015Q215$0.25$0.26$319.43 million$319.50 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/7/2015Q115$0.22$0.22$304.60 million$298.70 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/28/2015Q414$0.30$0.25$367.82 million$360.80 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/29/2014Q3$0.27$0.27$337.00 million$336.80 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/29/2014Q214$0.25$0.26$330.76 million$331.20 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/7/2014Q114$0.22$0.22$317.09 million$317.40 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/29/2014Q413$0.34$0.36$365.52 million$362.60 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/29/2013Q313$0.25$0.28$320.37 million$323.80 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/30/2013Q213$0.24$0.27$311.75 million$316.40 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/29/2013Q113$0.23$0.23$305.50 million$303.60 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/29/2013Q412$0.31$0.34$327.80 million$346.50 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/5/2012Q312$0.24$0.26$303.79 million$304.30 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/24/2012$0.25$0.25ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/25/2012$0.21$0.23ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/31/2012$0.28$0.31ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/2/2011$0.22$0.24ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/25/2011$0.23$0.23ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/27/2011$0.21$0.21ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/31/2011$0.25$0.26ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Qiagen NV (NASDAQ:QGEN)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20164$0.19$0.25$0.22
Q2 20164$0.25$0.29$0.27
Q3 20164$0.27$0.30$0.28
Q4 20163$0.33$0.36$0.35
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Qiagen NV (NASDAQ:QGEN)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Qiagen NV (NASDAQ:QGEN)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for Qiagen NV (NASDAQ:QGEN)
DateHeadline
07/24/16 10:05 AMIs $27 Price Target Attainable For Qiagen N.V. (NASDAQ:QGEN)? - Investor Newswire
07/24/16 10:05 AMIt's Earnings Time: What to Do with Qiagen NV (NASDAQ:QGEN) Stock - The Voice Registrar
07/20/16 06:53 PMShares Turning Downward: Qiagen NV (NASDAQ:QGEN) - TGP
07/19/16 04:01 AMQiagen NV Ord (NASDAQ:QGEN) Short Interest Increased By 14.75% - Press Telegraph
07/19/16 04:01 AMEarnings Focus and Crowd Sourced Sentiment Review for Qiagen N.V. (NASDAQ:QGEN) - TGP
07/18/16 02:07 PMQiagen sees call buying before earnings -
07/17/16 10:09 AMStrong Sell Calls For Qiagen N.V. (NASDAQ:QGEN) At 0 - Investor Newswire
07/14/16 09:38 AMQiagen NV : N.V. to Report Second Quarter and First Half of 2016 Results
07/14/16 04:14 AMQIAGEN N.V. to Report Second Quarter and First Half of 2016 Results - [PR Newswire] - VENLO, Netherlands, July 14, 2016 /PRNewswire/ -- QIAGEN N.V. (Nasdaq: QGEN) (Frankfurt: QIA) plans as previously announced to release its report on results for the second quarter and first half of 2016 ...
07/13/16 06:25 PMJohnston Asset Management Corp Decreased Stake in Qiagen Nv (NASDAQ:QGEN) by $50.48 Million as Shares ... - Consumer Eagle
07/12/16 06:17 PMQiagen N.V. (NASDAQ:QGEN) Wall Street Analyst Recommendation Outlook - Telanagana Press
07/12/16 10:24 AMQiagen NV Ord (NASDAQ:QGEN) Sellers Increased By 14.75% Their Shorts - Consumer Eagle
07/10/16 05:17 PMQiagen N.V. (NASDAQ:QGEN): Check on Company Stock Performance - Press Telegraph
07/10/16 05:17 PMAccounts Payable For Qiagen NV (NASDAQ:QGEN) Reach $38.93 - RealistInvestor.com
07/10/16 05:17 PMQiagen N.V. (NASDAQ:QGEN) Broker Price Targets For The Coming Week - Fiscal Standard
07/09/16 09:08 AMIs $27 Within Reach For Qiagen N.V. (NASDAQ:QGEN)? - Investor Newswire
07/09/16 09:08 AMQiagen N.V. (NASDAQ:QGEN) Current Analyst Ratings - Fiscal Standard
07/07/16 08:50 AMShares Declining and Worrying Investors: Qiagen NV (NASDAQ:QGEN) - Telanagana Press
07/07/16 08:50 AMCompany Stock Focus for Qiagen N.V. (NASDAQ:QGEN): Which Way Will Shares Head? - Press Telegraph
07/07/16 08:50 AMQiagen N.V. (QGEN) : Analyst Rating Update - Trade Calls
07/06/16 01:37 PMETF’s with exposure to QIAGEN NV : July 6, 2016 -
07/06/16 07:21 AMQIAGEN NV breached its 50 day moving average in a Bearish Manner : QGEN-US : July 6, 2016 -
07/06/16 02:31 AMExiqon A/S - CALL FOR REDEMPTION OF MINORITY SHAREHOLDERS IN EXIQON A/S UNDER SECTIONS 70 AND 72 OF THE DANISH COMPANIES ACT - [at noodls] - Exiqon A/S Company Announcement CALL FOR REDEMPTION OF MINORITY SHAREHOLDERS IN EXIQON A/S UNDER SECTIONS 70 AND 72 OF THE DANISH COMPANIES ACT Copenhagen, 2016-07-06 09:17 CEST (GLOBE NEWSWIRE) -- As ...
07/05/16 09:05 AMQIAGEN NV :QGEN-US: Earnings Analysis: For the six months ended December 31, 2015 : July 5, 2016 -
07/04/16 10:40 AMQiagen N.V. (NASDAQ:QGEN) Stock Focus and Earnings Glance - Telanagana Press
07/04/16 10:40 AMQiagen N.V. (NASDAQ:QGEN) Analyst Rating in Focus - Investor Newswire
07/03/16 10:11 AMQiagen N.V. (NASDAQ:QGEN) Expected to Reach Highs Of $27 - Investor Newswire
06/30/16 06:17 PMAnalyst Rating Update on Qiagen N.V. (QGEN) - TheFounders Daily
06/29/16 05:54 PMDekabank Deutsche Girozentrale Decreased Stake in Qiagen Nv (NASDAQ:QGEN) by $7.83 Million as Shares Declined - Engelwood Daily
06/28/16 05:57 PMQiagen N.V. (NASDAQ:QGEN) Updated Price Targets - FTSE News
06/28/16 05:57 PMQiagen N.V. (NASDAQ:QGEN): Reviewing Stock Performance - Press Telegraph
06/27/16 10:10 AMNext Weeks Broker Price Targets For Qiagen N.V. (NASDAQ:QGEN) - Fiscal Standard
06/26/16 05:04 PMStock Sentiment Review for :Qiagen N.V. (NASDAQ:QGEN) - Press Telegraph
06/25/16 05:27 PMStrong Sell Calls Recommendations For Qiagen N.V. (NASDAQ:QGEN) At 0 - Investor Newswire
06/25/16 05:27 PMQiagen N.V. (NASDAQ:QGEN): Update on Stock Performance - Press Telegraph
06/24/16 06:04 PMQiagen (QGEN) Completes Exiqon Tender Offer - StreetInsider.com
06/24/16 06:04 PMCan Qiagen NV (NASDAQ:QGEN) Meet Analysts Expectations? - Stocks Daily
06/24/16 07:33 AMQIAGEN NV breached its 50 day moving average in a Bullish Manner : QGEN-US : June 24, 2016 -
06/23/16 08:42 AMQiagen NV : Announces Successful Completion of Tender Offer for Shares in Exiqon
06/23/16 04:59 AMQIAGEN announces successful completion of tender offer for shares in Exiqon - [at noodls] - Transaction will enhance leadership position in RNA solutions from Sample to Insight Venlo, The Netherlands, June 23, 2016- QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced the ...
06/22/16 10:44 AMQiagen N.V. (NASDAQ:QGEN) Analyst Rating Consensus - TheFounders Daily
06/21/16 10:22 AMQiagen NV : joins consortium to map microbial genomes in 54 cities
06/18/16 10:09 AMStrong Buy Calls Count For Qiagen N.V. (NASDAQ:QGEN) At 2 - Investor Newswire
06/16/16 06:15 PMIt’s Earnings Time: What to Do with Qiagen NV (NASDAQ:QGEN) Stock
06/15/16 10:34 AMAnalyst Price Target Update on Qiagen N.V. (NASDAQ:QGEN) - TheFounders Daily
06/15/16 10:34 AMIt's Earnings Time: What to Do with Qiagen NV (NASDAQ:QGEN) Stock - iStreetWire
06/15/16 07:33 AMQiagen???s QIAsure Test to Determine Cervical Cancer Risks -
06/15/16 12:29 AMMDxHealth (R): Grants QIAGEN Rights to MSP Technology for QIAsure Methylation Test for Cervical Cancer Risk - [at noodls] - IRVINE, CA, and HERSTAL, BELGIUM - June 15, 2016 - MDxHealth SA (Euronext: MDXH.BR), announced today that it has granted a non-exclusive worldwide license for its patented methylation-specific PCR (MSP) ...
06/14/16 05:46 PMQiagen NV : Launches QIAsure Methylation Test to Determine Cervical Cancer Risk
06/14/16 03:19 PMQIAGEN launches QIAsure Methylation Test to determine cervical cancer risk - [at noodls] - New follow-up assayhelps stratify patients with transforming HPV infections Hilden, Germany, and Salzburg, Austria, June 14, 2016- QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced ...

Social

About Qiagen NV

Qiagen NV logoQIAGEN N.V. (QIAGEN) is a holding company. The Company and its subsidiaries are engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Sample to Insight solutions are composed of sample and assay technologies, bioinformatics and automation systems. Its bioinformatics solutions interpret data to provide actionable insights. Its automation platforms tie these together in molecular testing workflows-from Sample to Insight. Its Sample to Insight molecular technologies are applicable across a range of applications and customer classes through over 500 core consumable products, as well as instruments that automate the use of these products for sample preparation, analysis and interpretation. Its bioinformatics solutions connect laboratory workflows and process amounts of genomic data, enabling scientists or clinicians to decide on further action. It offers solutions in molecular diagnostics, applied testing, pharma and academia.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Research Services
  • Sub-Industry: Life Sciences Tools & Services
  • Exchange: NASDAQ
  • Symbol: QGEN
  • CUSIP: N7248210
Key Metrics:
  • Previous Close: $23.13
  • 50 Day Moving Average: $21.81
  • 200 Day Moving Average: $22.02
  • P/E Ratio: 44.48
  • P/E Growth: 2.22
  • Market Cap: $5.40B
  • Beta: 0.9
  • Current Year EPS Consensus Estimate: $1.08 EPS
  • Next Year EPS Consensus Estimate: $1.19 EPS
Additional Links:
Qiagen NV (NASDAQ:QGEN) Chart for Tuesday, July, 26, 2016